Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Seton Healthcare
mi
from
Austin, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Seton Healthcare
mi
from
Austin, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of Texas at El Paso
mi
from
El Paso, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of Texas at El Paso
mi
from
El Paso, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Memorial Hermann Hospital-Medical Center
mi
from
Houston, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Memorial Hermann Hospital-Medical Center
mi
from
Houston, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of Wisconsin-Madison
mi
from
Madison, WI
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of Wisconsin-Madison
mi
from
Madison, WI
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Wheaton Franciscan Healthcare
mi
from
Milwaukee, WI
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Wheaton Franciscan Healthcare
mi
from
Milwaukee, WI
Evaluation of Safety of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
A Clinical Evaluation of Safety of Latanoprost Ophthalmic Solution When Administered Once Daily in Subjects With Open Angle Glaucoma or Ocular Hypertension: an Open Label Study
Status: Archived
Cornerstone Eye Care
mi
from
High Point, NC
Evaluation of Safety of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
A Clinical Evaluation of Safety of Latanoprost Ophthalmic Solution When Administered Once Daily in Subjects With Open Angle Glaucoma or Ocular Hypertension: an Open Label Study
Status: Archived
Updated: 1/1/1970
Cornerstone Eye Care
mi
from
High Point, NC
Efficacy and Safety of 2 Formulations of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
Comparison of the Efficacy and Safety of 2 Formulations of Latanoprost Ophthalmic Solution When Administered Once Daily in Subjects With Open Angle Glaucoma or Ocular Hypertension
Status: Archived
David Shulman
mi
from
San Antonio, TX
Efficacy and Safety of 2 Formulations of Latanoprost Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
Comparison of the Efficacy and Safety of 2 Formulations of Latanoprost Ophthalmic Solution When Administered Once Daily in Subjects With Open Angle Glaucoma or Ocular Hypertension
Status: Archived
Updated: 1/1/1970
David Shulman
mi
from
San Antonio, TX
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Edward S. Cooper Practice of General Internal Medicine
mi
from
Philadelphia, PA
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Updated: 1/1/1970
Edward S. Cooper Practice of General Internal Medicine
mi
from
Philadelphia, PA
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Pennington Biodmedical Research
mi
from
Baton Rouge, LA
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Updated: 1/1/1970
Pennington Biodmedical Research
mi
from
Baton Rouge, LA
B-type Natriuretic Peptide (BNP) in Human Hypertension
Clinical Proteomics and Protein Therapeutics in Human Hypertension (BNP in Human Hypertension - Phase 1)
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
B-type Natriuretic Peptide (BNP) in Human Hypertension
Clinical Proteomics and Protein Therapeutics in Human Hypertension (BNP in Human Hypertension - Phase 1)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension
Role of EECP Therapy in Patients With Resistant Hypertension
Status: Archived
Albert Einstein College of Medicine
mi
from
Bronx, NY
Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension
Role of EECP Therapy in Patients With Resistant Hypertension
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
mi
from
Bronx, NY
Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension
Effect of Treating Sleep Disorder Breathing Therapy in Patients With Resistant Hypertension
Status: Archived
Albert Einstein College of Medicine
mi
from
Bronx, NY
Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension
Effect of Treating Sleep Disorder Breathing Therapy in Patients With Resistant Hypertension
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
mi
from
Bronx, NY
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
Status: Archived
Creighton University
mi
from
Omaha, NE
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
Status: Archived
Updated: 1/1/1970
Creighton University
mi
from
Omaha, NE
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Harbor-UCLA Med Ctr
mi
from
Torrance, CA
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Updated: 1/1/1970
Harbor-UCLA Med Ctr
mi
from
Torrance, CA
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Albert Einstein College of Medicine
mi
from
Bronx, NY
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
mi
from
Bronx, NY
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Updated: 1/1/1970
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Harbor-UCLA Med Ctr
mi
from
Torrance, CA
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Updated: 1/1/1970
Harbor-UCLA Med Ctr
mi
from
Torrance, CA
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Albert Einstein College of Medicine
mi
from
Bronx, NY
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
mi
from
Bronx, NY
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Updated: 1/1/1970
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Restoring Sleep Homeostasis to Lower Blood Pressure
Restoring Sleep Homeostasis to Lower Blood Pressure: A Behavioral Prevention and Treatment Approach
Status: Archived
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Restoring Sleep Homeostasis to Lower Blood Pressure
Restoring Sleep Homeostasis to Lower Blood Pressure: A Behavioral Prevention and Treatment Approach
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Treating to Target for Patients With Hypertension
Treating to Target for Patients With Hypertension
Status: Archived
San Francisco General Hospital
mi
from
San Francisco, CA
Treating to Target for Patients With Hypertension
Treating to Target for Patients With Hypertension
Status: Archived
Updated: 1/1/1970
San Francisco General Hospital
mi
from
San Francisco, CA
Behavioral Study to Control Blood Pressure
Effect of a Novel Behavioral Intervention on Blood Pressure Control in Hypertension Patients
Status: Archived
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Behavioral Study to Control Blood Pressure
Effect of a Novel Behavioral Intervention on Blood Pressure Control in Hypertension Patients
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Status: Archived
Robert Bourge MD
mi
from
Birmingham, AL
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Status: Archived
Updated: 1/1/1970
Robert Bourge MD
mi
from
Birmingham, AL
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Status: Archived
Ron Oudiz
mi
from
Torrance, CA
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Status: Archived
Updated: 1/1/1970
Ron Oudiz
mi
from
Torrance, CA
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Status: Archived
Charles Burger MD
mi
from
Jacksonville, FL
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
Status: Archived
Updated: 1/1/1970
Charles Burger MD
mi
from
Jacksonville, FL
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetes (The Effort Trial)
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetes
Status: Archived
University of Chicago
mi
from
Chicago, IL
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetes (The Effort Trial)
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetes
Status: Archived
Updated: 1/1/1970
University of Chicago
mi
from
Chicago, IL
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of a Single Dose of 1 mg Riociguat (BAY63-2521) on Myocardial Contractility and Relaxation in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (PH-sLVD)
Status: Archived
Clinical Trial Facility
mi
from
Boston, MA
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of a Single Dose of 1 mg Riociguat (BAY63-2521) on Myocardial Contractility and Relaxation in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (PH-sLVD)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Boston, MA
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of a Single Dose of 1 mg Riociguat (BAY63-2521) on Myocardial Contractility and Relaxation in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (PH-sLVD)
Status: Archived
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of a Single Dose of 1 mg Riociguat (BAY63-2521) on Myocardial Contractility and Relaxation in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (PH-sLVD)
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Brigham and Women's Hosp
mi
from
Boston, MA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Updated: 1/1/1970
Brigham and Women's Hosp
mi
from
Boston, MA
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Woodhull Medical and Mental Health Center
mi
from
Brooklyn, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Updated: 1/1/1970
Woodhull Medical and Mental Health Center
mi
from
Brooklyn, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Bellevue Hospital Center
mi
from
New York, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Updated: 1/1/1970
Bellevue Hospital Center
mi
from
New York, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Governeur Hospital
mi
from
New York, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Updated: 1/1/1970
Governeur Hospital
mi
from
New York, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Lincoln Hospital and Harlem Hospital
mi
from
New York, NY
Practice-based Trial of Blood Pressure Control in African Americans
Practice-based Trial of Blood Pressure Control in African Americans
Status: Archived
Updated: 1/1/1970
Lincoln Hospital and Harlem Hospital
mi
from
New York, NY
Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab
Comparative Blood Pressure Effects of Nebivolol Versus Lisinopril in Patients With New Onset or Exacerbated Hypertension Induced by Bevacizumab: a Crossover Study
Status: Archived
University of Mississippi
mi
from
Jackson, MS
Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab
Comparative Blood Pressure Effects of Nebivolol Versus Lisinopril in Patients With New Onset or Exacerbated Hypertension Induced by Bevacizumab: a Crossover Study
Status: Archived
Updated: 1/1/1970
University of Mississippi
mi
from
Jackson, MS
Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
Evaluating the Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
Evaluating the Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Biomarkers of Metabolic Syndrome and Prediabetes
Assessing Salivary Biomarkers for Risk Stratification in Metabolic Syndrome
Status: Archived
West Virginia School of Osteopathic Medicine
mi
from
Lewisburg, WV
Biomarkers of Metabolic Syndrome and Prediabetes
Assessing Salivary Biomarkers for Risk Stratification in Metabolic Syndrome
Status: Archived
Updated: 1/1/1970
West Virginia School of Osteopathic Medicine
mi
from
Lewisburg, WV
Pilot Study Evaluating the Safety and Performance of the GeNO Nitrosyl Delivery System for Inhaled Nitric Oxide
An Open Label Pilot Study Evaluating Preliminary Safety and Performance of the GeNO Nitrosyl Delivery System
Status: Archived
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Pilot Study Evaluating the Safety and Performance of the GeNO Nitrosyl Delivery System for Inhaled Nitric Oxide
An Open Label Pilot Study Evaluating Preliminary Safety and Performance of the GeNO Nitrosyl Delivery System
Status: Archived
Updated: 1/1/1970
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Updated: 1/1/1970
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Vanderiblt University Medical Center
mi
from
Nashville, TN
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Status: Archived
Updated: 1/1/1970
Vanderiblt University Medical Center
mi
from
Nashville, TN
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Pfizer Investigational Site
mi
from
Fayetteville, AR
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Fayetteville, AR
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Pfizer Investigational Site
mi
from
Bloomingdale, IL
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Bloomingdale, IL
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Darien Pediatric Associates
mi
from
Darien, CT
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
mi
from
Darien, CT
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Pfizer Investigational Site
mi
from
Biloxi, MS
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension
A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study To Evaluate The Safety, Tolerability And Efficacy Of Once Daily PF-04971729 And Hydrochlorothiazide In Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic And Blood Pressure Control
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Biloxi, MS